Taking Tylenol during pregnancy has no link to autism, new study finds
A new study from Denmark, tracking over 1.5 million children born between 1997 and 2022, found no link between acetaminophen (Tylenol) use during pregnancy and autism diagnoses. The research, published in JAMA Pediatrics, showed a lower rate of autism in children exposed to Tylenol in utero compared to those who were not.

Briefing Summary
AI-generatedA new study from Denmark, tracking over 1.5 million children born between 1997 and 2022, found no link between acetaminophen (Tylenol) use during pregnancy and autism diagnoses. The research, published in JAMA Pediatrics, showed a lower rate of autism in children exposed to Tylenol in utero compared to those who were not. This contradicts a previous US review suggesting a potential relationship and warnings from the Trump administration, which led to a drop in Tylenol use among pregnant women. Despite these concerns and a planned FDA label change, the study supports the safety of Tylenol during pregnancy for pain and fever relief. Similar findings were reported in a 2024 Swedish study, suggesting a strong genetic component to autism.
Article analysis
Model · rule-basedKey claims
5 extractedTylenol use among pregnant women in emergency rooms dropped by 10% after the September announcement.
Trump cautioned several times against taking the pain reliever during pregnancy.
Autism was diagnosed in 1.8% of children who were exposed to Tylenol and 3% of those who weren’t.
Taking acetaminophen during pregnancy has no effect on later autism diagnoses, according to a new study from Denmark.
A US review of existing studies in 2025 found a potential relationship, but it wasn’t clear whether confounders were at play.